Exact Sciences Corporation shares rise 2.11% intraday as biotech sector gains momentum.

Exact Sciences Corporation rose 2.11% intraday, with the biotech sector experiencing a pivotal phase fueled by scientific breakthroughs, accelerated regulatory approvals, and a surge of strategic dealmaking. The Nasdaq Biotechnology Index has posted strong gains, signaling renewed investor confidence. The FDA is clearing a record number of novel therapies, while global mergers and acquisitions have climbed past $105 billion, a seven percent increase from last year.